Science Explorer Back to mapMap
Discussion
Institution · Ente Ospedaliero Cantonale

Most cited papers from Ente Ospedaliero Cantonale

Ente Ospedaliero Cantonale

What are the most cited papers from Ente Ospedaliero Cantonale?

The most cited paper from Ente Ospedaliero Cantonale is "The gut-liver axis in liver disease: Pathophysiological basis for therapy" (Agustı́n Albillos, Andrea De Gottardi, María Rescigno, 2019), with 2,173 citations. Next come "Clinical classification of pulmonary hypertension" (1,906) and "HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD" (1,672).

Showing 50 of 60 papers. Every paper with more than 279 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 The gut-liver axis in liver disease: Pathophysiological basis for therapy Agustı́n Albillos, Andrea De Gottardi, María Rescigno · Journal of Hepatology Open access 14 Oct 2019 2,173
2 Clinical classification of pulmonary hypertension Gérald Simonneau, Nazzareno Galiè, Lewis J. Rubin et al. · Journal of the American College of Cardiology Open access Jun 2004 1,906
3 HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD Paul A. Imbach, Vincenzo D’Apuzzo, Andreas Hirt et al. · The Lancet Jun 1981 1,672
4 Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology Luca Piccoli et al. · Cell Open access 16 Sep 2020 1,646
5 The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee Elı́as Campo et al. · Blood Open access 2 Jun 2022 1,603
6 Effect of Prone Positioning on the Survival of Patients with Acute Respiratory Failure Luciano Gattinoni, Gianni Tognoni, Antonio Pesenti et al. · New England Journal of Medicine Open access 23 Aug 2001 1,289
7 Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19 Christoph D. Spinner et al. · JAMA Open access 21 Aug 2020 1,283
8 Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift Elisabetta Cameroni et al. · Nature Open access 23 Dec 2021 1,212
9 Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study Andri Rauch et al. · Gastroenterology Open access 12 Jan 2010 1,143
10 Obstructive sleep disordered breathing in 2- to 18-year-old children: diagnosis and management Athanasios G. Kaditis, María Luz Alonso Álvarez, An N. Boudewyns et al. · European Respiratory Journal Open access 5 Nov 2015 915
11 Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity Emma C. Thomson et al. · Cell Open access 28 Jan 2021 660
12 Morbidity and Aging in HIV-Infected Persons: The Swiss HIV Cohort Study Barbara Katharina Hasse, Bruno Ledergerber, Hansjakob Furrer et al. · Clinical Infectious Diseases Open access 13 Oct 2011 621
13 Current options and recommendations for the treatment of thoracic aortic pathologies involving the aortic arch: an expert consensus document of the European Association for Cardio-Thoracic surgery (EACTS) and the European Society for Vascular Surgery (ESVS) Martin Czerny et al. · European Journal of Cardio-Thoracic Surgery Open access 22 Aug 2018 618
14 Metabolic modulation of tumours with engineered bacteria for immunotherapy Fernando Pablo Canale, Camilla Basso, Gaia Antonini et al. · Nature 6 Oct 2021 617
15 Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’ 1 Andrés J.M. Ferreri et al. · British Journal of Haematology Open access Oct 2004 616
16 The epidemiology of non‐alcoholic fatty liver disease Stefano Bellentani · Liver International Open access 2017 615
17 Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial Andrés J.M. Ferreri et al. · The Lancet Haematology Open access 9 Apr 2016 612
18 Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk Marco Valgimigli et al. · New England Journal of Medicine Open access 28 Aug 2021 589
19 Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis Christian Barro, Pascal Benkert, Giulio Disanto et al. · Brain 13 May 2018 549
20 The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology Jonel Trebicka et al. · Journal of Hepatology Open access126 authors 13 Jul 2020 526
21 Definition, Diagnosis, and Management of Intravascular Large B-Cell Lymphoma: Proposals and Perspectives From an International Consensus Meeting Maurilio Ponzoni, Andrés J.M. Ferreri, Elı́as Campo et al. · Journal of Clinical Oncology Open access 18 Jun 2007 494
22 The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm Homie A. Razavi et al. · Journal of Viral Hepatitis Open access 8 Apr 2014 489
23 Weight Loss, Weight Maintenance, and Improved Cardiovascular Risk Factors after 2 Years Treatment with Orlistat for Obesity Stephan Rössner, Lars Sjöström, Rudolf Noack et al. · Obesity Research Open access 2000 478
24 Mutations in Sarcomere Protein Genes in Left Ventricular Noncompaction Sabine Klaassen, Susanne Probst, Erwin Notker Oechslin et al. · Circulation Open access 27 May 2008 457
25 Clinical impact of programmed cell death ligand 1 expression in colorectal cancer Raoul Andre Droeser et al. · European Journal of Cancer 13 Mar 2013 449
26 25-Hydroxyvitamin D Concentrations Are Lower in Patients with Positive PCR for SARS-CoV-2 Antonio D’Avolio, Valeria Avataneo, Alessandra Manca et al. · Nutrients Open access 9 May 2020 446
27 Broad betacoronavirus neutralization by a stem helix–specific human antibody Dora Pinto et al. · Science Open access 3 Aug 2021 445
28 Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study Sandy Amorim, Anastasios Stathis, Mary Gleeson et al. · The Lancet Haematology 19 Mar 2016 431
29 International Guidelines for Management of Metastatic Breast Cancer: Can Metastatic Breast Cancer Be Cured? Olivia Pagani, Elżbieta Senkus, WC Wood et al. · JNCI Journal of the National Cancer Institute Open access 10 Mar 2010 427
30 Global epidemiology of non‐alcoholic fatty liver disease/non‐alcoholic steatohepatitis: What we need in the future Ana Ruth Araújo, Natalia Rosso, Giorgio Bedogni et al. · Liver International Feb 2018 424
31 A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel Markus Cornberg et al. · Liver International ReviewOpen access 8 Jun 2011 413
32 Primary extranodal non-Hodgkin's lymphomas. Part 1: Gastrointestinal, cutaneous and genitourinary lymphomas Emanuele Zucca, Enrico Roggero, Francesco Bertoni et al. · Annals of Oncology Open access Aug 1997 408
33 A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy. Claudio Ponticelli et al. · Journal of the American Society of Nephrology Mar 1998 392
34 Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial Andrés J.M. Ferreri et al. · The Lancet Haematology Open access 18 Oct 2017 390
35 Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness Davide Rossi et al. · Blood Open access 29 Oct 2011 371
36 Decreasing mortality and changing patterns of causes of death in the S wiss HIV C ohort S tudy Rainer K. Weber, M Ruppik, Martin Rickenbach et al. · HIV Medicine Open access 24 Sep 2012 362
37 Randomized Placebo-Controlled Trial of Ursodeoxycholic Acid With Vitamin E in Nonalcoholic Steatohepatitis Jean‐François Dufour, Carl M. Oneta, Jean‐Jacques Gonvers et al. · Clinical Gastroenterology and Hepatology Open access Dec 2006 357
38 Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up T. Powles, Laurence K. Albiges, Axel Bex et al. · Annals of Oncology Open access 22 May 2024 356
39 EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II—2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer Derya Tilki et al. · European Urology Open access 29 Apr 2024 354
40 Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Emanuele Zucca, Luca Arcaini, Christian Buske et al. · Annals of Oncology Open access 2020 353
41 Editor's Choice – Current Options and Recommendations for the Treatment of Thoracic Aortic Pathologies Involving the Aortic Arch: An Expert Consensus Document of the European Association for Cardio-Thoracic Surgery (EACTS) & the European Society for Vascular Surgery (ESVS) Martin Czerny et al. · European Journal of Vascular and Endovascular Surgery Open access 11 Oct 2018 348
42 Elevated Troponin in Patients With Coronavirus Disease 2019: Possible Mechanisms Gregorio Tersalvi, Marco Vicenzi, Davide Calabretta et al. · Journal of Cardiac Failure Open access 18 Apr 2020 342
43 Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia Pierluigi Quadri, Claudia Fragiacomo, Rita Pezzati et al. · American Journal of Clinical Nutrition Open access Jul 2004 340
44 Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis Nicolò Pernigoni et al. · Science 8 Oct 2021 334
45 Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study Daiana Stolz, Nicholas A. Smyrnios, Philippe Eggimann et al. · European Respiratory Journal Open access 24 Sep 2009 333
46 The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration Michele Fusaroli et al. · Drug Safety Open access 7 May 2024 332
47 Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study Jacques Fellay, Bruno Ledergerber, Enos Bernasconi et al. · The Lancet Open access Oct 2001 329
48 N-Acetylcysteine Enhances Recovery From Acute Lung Injury in Man Peter M. Suter, Guido M. Domenighetti, Marie‐Denise Schaller et al. · CHEST Journal 1994 325
49 Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network Markus Tiemann et al. · British Journal of Haematology 25 Aug 2005 317
50 Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors Oriol Juanola, Sebastián Martínez‐López, Rubén Francés et al. · International Journal of Environmental Research and Public Health Open access 14 May 2021 310

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.